FDA reports new deaths with diabetes drug Byetta

August 18, 2008 By MATTHEW PERRONE , AP Business Writer

(AP) -- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Explore further: New drug candidate prolongs the lives of pancreatic cancer patients

Related Stories

Researchers create drug to keep tumor growth switched off

February 11, 2010

A novel -- and rapid -- anti-cancer drug development strategy has resulted in a new drug that stops kidney and pancreatic tumors from growing in mice. Researchers at the Moores Cancer Center at the University of California, ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (1) Aug 18, 2008
Pretty bad when a drug for a condition that can be controlled by dietary means causes people to die of pancreatitis. What does the FDA? Require a warning.

In contrast, when a natural nutrient product causes similar trouble, the answer is usually to ban that product outright.

Double standard?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.